GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Stoke Therapeutics Inc (STU:0GT) » Definitions » Policy Acquisition Expense

Stoke Therapeutics (STU:0GT) Policy Acquisition Expense


View and export this data going back to 2019. Start your Free Trial

What is Stoke Therapeutics Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Stoke Therapeutics (STU:0GT) Business Description

Traded in Other Exchanges
Address
45 Wiggins Avenue, Bedford, MA, USA, 01730
Stoke Therapeutics Inc is engaged in addressing the underlying causes of severe diseases by upregulating protein expression with RNA-based medicines. Using its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, it is developing antisense oligonucleotides (ASOs) to selectively restore protein levels. The company primarily operates in the U.S.